Evidence map›Paper›PMID 15202764›Full record

ArticleNeurochemical research2004

Hypothalamic proline-rich polypeptide protects brain neurons in aluminum neurotoxicosis.

A A Galoyan, V A Shakhlamov, M I Aghajanov, H G Vahradyan

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

A A GaloyanH. Buniatian Institute of Biochemistry, Yerevan, The Republic of Armenia. galoyan@sci.am
V A Shakhlamov
M I Aghajanov
H G Vahradyan
Yerevan State Medical University · AMH.Buniatian Institute of Biochemistry · AMResearch Institute of Human Morphology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The damaging effect of aluminum ions (Al3+) on the organism is widely investigated in clinics and experiments that indicate its role as a participant in the synthesis of precursors for amyloid proteins and as a potential agent in the ethiology of Alzheimer's disease. It has been shown that Al produces neurotoxic effects. We established that AlCl3 produces degenerative changes in the ultrastructure of Hasserian neurinoma cells in vitro and in L929 fibroblast cells. Proline-rich peptide-1 (PRP-1) isolated from neurosecretory granules of bovine neurohypophysis is a potent antineurodegenerative agent against spinal cord hemisection and crush syndrome-induced neurodegeneration of brain and spinal cord neurons. PRP-1 is one of the neurotrophic brain factors. By electron microscopic study of the rat hippocampus and other tissues, we succeeded in visualizing the epithelioprotectory effect of PRP-1, contributing as a powerful agent in removal of aluminum accumulation in different tissues in experimental aluminum neurotoxicosis.

Indexed as

AluminumAluminum ChlorideAluminum CompoundsAlzheimer DiseaseAnimalsAntitoxinsBrainCattleChloridesDisease Models, AnimalHippocampusInsulin-Like Growth Factor IMaleMiceNeuroprotective AgentsNeurotoxinsAluminumAluminum ChlorideAluminum CompoundsAntitoxinsChloridesInsulin-Like Growth Factor INeuroprotective AgentsNeurotoxinsPeptides

Identifiers

PMID15202764
OpenAlexW2075758135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.